Figure 4. Knockdown of GAP43 in the L5 dorsal root ganglion reduces pain behaviors and GAP43 upregulation in the SNL model. siRNA directed against GAP43 or control nontargeting siRNA was injected into the L5 DRG immediately prior to implementing the SNL model. a–f, Sections were obtained 4 d later. DRG sections from cellular regions (a–c) or axonal regions (d–f) stained for GAP43 (red) and neuronal marker NeuN (green) from normal (a, d), SNL + control siRNA-injected (b, e) and SNL + GAP43-siRNA injected (c, f) DRGs. g, h, Summary data of GAP43 intensity from cellular (g) and axonal (h) regions. ***p < 0.001, significant differences between control siRNA groups and both other groups; ANOVA with Dunnett’s post-test. g, F(2,12) =107.70; h, F(2,12) = 62.77; n = 5 rats/group (3 males, 2 females), with 19–33 soma region sections per rat and 6–12 axonal regions per rat. Effect of siRNA injection on pain behaviors: i, Threshold for withdrawal responses to von Frey filaments (dotted line indicates baseline; F(1,10) = 119.37). j, Cold allodynia (withdrawal responses to a drop of acetone; F(1,10) = 10.77). k, Dynamic allodynia (withdrawal responses to light stroking with a fine cotton wisp; F(1,10) = 124.59). l, Guarding behavior score (maximum value is 3; F(1,10) = 4.94). *p < 0.05; **p < 0.01; ***p < 0.001, significant difference between the two groups at the indicated time points (two-way repeated measures ANOVA with Bonferroni’s post-test). N = 6 rats/group (3 males, 3 female). PWT, paw withdrawal threshold.